Crit Care Med:感染性休克患者再次入院常见原因分析

2015-04-04 MedSci译 MedSci原创

目标:感染性休克患者会导致长期患病率和死亡率的增加,然而,很少人知道出院后的幸存者实施院内急救护理的相关情况。这项研究的目的在于探究出院后30天内再送入急诊科和入院的患者的频率、时间、原因和相关风险因素。设计:该研究为回顾性队列研究,且不实施任何干预措施。地点:实验在美国三家学术性医院进行。参与人员:参与人员为2007-2010年间感染性休克的患者(患者血清乳酸脱氢酶浓度大于等于4 mmol/L

目标:
感染性休克患者会导致长期患病率和死亡率的增加,然而,很少人知道出院后的幸存者实施院内急救护理的相关情况。这项研究的目的在于探究出院后30天内再送入急诊科和入院的患者的频率、时间、原因和相关风险因素。

设计:
该研究为回顾性队列研究,且不实施任何干预措施。

地点:
实验在美国三家学术性医院进行。

参与人员:
参与人员为2007-2010年间感染性休克的患者(患者血清乳酸脱氢酶浓度大于等于4 mmol/L 或持续性低血压)并且患者活着出院后去了一家非临终关怀机构继续治疗。

结果:
主要指标是30天内由所有原因引起的患者再次入院和去急诊(三家医院的任何一家医院都可)就诊(包括去急诊对症治疗的患者)的患者人数和次数。在269名高危幸存者中,有63名患者出院后30天内又重新入院诊治(占23.4%,95%的可信区间为18.2到28.5),且有12名患者去急诊进行了对症治疗(占4.5%,95%可信区间为2.3到7.7)。出院后15天内重新入院的占75%,更像是肿瘤科的病人(P=0.001),并且他们住院时间更长(P=0.04).有重新入院所有病例中有16%是由于患者频繁受到其他威胁生命的并且可导致死亡或转入临终关怀机构的因素入院。在所有的入院原因中,认为与感染性休克有关而入院的原因占78%(在所有入院共63个因素中该类原因有49个)。最常见的原因是因为存在相关感染而入院就诊,在所有入院患者中因该原因入院的患者占46%,其次是心血管疾病或血栓阻塞导致患者入院的因素(占18%)。

结论:
对于感染性休克患者使用院内急救护理已经普遍开始实施。出院15天内入院的患者似乎更多地是由于某种突发原因,而且会导致患病率和死亡率只升不减。我们应该多关注潜在的、研究所发现的普遍并发症并深入研究。

原始出处:
Ortego A, Gaieski DF, Fuchs BD, Jones T, Halpern SD, Small DS, Sante SC, Drumheller B, Christie JD, Mikkelsen ME.Hospital-based acute care use in survivors of septic shock. Crit Care Med. 2015 Apr;43(4):729-37.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1655336, encodeId=570e1655336a2, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Wed Jul 08 14:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30394, encodeId=58ea30394d2, content=可供休克因素太多,护理太重要了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b65e1629844, createdName=1dd87579m10(暂无匿称), createdTime=Sat Jul 04 10:12:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606461, encodeId=48c4160646102, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Apr 06 14:23:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19550, encodeId=4a1b19550a8, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c8e1619533, createdName=cd90, createdTime=Sun Apr 05 20:43:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19541, encodeId=89f1195413b, content=会死人的病, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Sun Apr 05 19:55:00 CST 2015, time=2015-04-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1655336, encodeId=570e1655336a2, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Wed Jul 08 14:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30394, encodeId=58ea30394d2, content=可供休克因素太多,护理太重要了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b65e1629844, createdName=1dd87579m10(暂无匿称), createdTime=Sat Jul 04 10:12:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606461, encodeId=48c4160646102, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Apr 06 14:23:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19550, encodeId=4a1b19550a8, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c8e1619533, createdName=cd90, createdTime=Sun Apr 05 20:43:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19541, encodeId=89f1195413b, content=会死人的病, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Sun Apr 05 19:55:00 CST 2015, time=2015-04-05, status=1, ipAttribution=)]
    2015-07-04 1dd87579m10(暂无匿称)

    可供休克因素太多,护理太重要了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1655336, encodeId=570e1655336a2, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Wed Jul 08 14:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30394, encodeId=58ea30394d2, content=可供休克因素太多,护理太重要了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b65e1629844, createdName=1dd87579m10(暂无匿称), createdTime=Sat Jul 04 10:12:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606461, encodeId=48c4160646102, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Apr 06 14:23:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19550, encodeId=4a1b19550a8, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c8e1619533, createdName=cd90, createdTime=Sun Apr 05 20:43:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19541, encodeId=89f1195413b, content=会死人的病, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Sun Apr 05 19:55:00 CST 2015, time=2015-04-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1655336, encodeId=570e1655336a2, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Wed Jul 08 14:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30394, encodeId=58ea30394d2, content=可供休克因素太多,护理太重要了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b65e1629844, createdName=1dd87579m10(暂无匿称), createdTime=Sat Jul 04 10:12:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606461, encodeId=48c4160646102, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Apr 06 14:23:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19550, encodeId=4a1b19550a8, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c8e1619533, createdName=cd90, createdTime=Sun Apr 05 20:43:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19541, encodeId=89f1195413b, content=会死人的病, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Sun Apr 05 19:55:00 CST 2015, time=2015-04-05, status=1, ipAttribution=)]
    2015-04-05 cd90

    继续关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1655336, encodeId=570e1655336a2, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Wed Jul 08 14:23:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30394, encodeId=58ea30394d2, content=可供休克因素太多,护理太重要了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b65e1629844, createdName=1dd87579m10(暂无匿称), createdTime=Sat Jul 04 10:12:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606461, encodeId=48c4160646102, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Apr 06 14:23:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19550, encodeId=4a1b19550a8, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c8e1619533, createdName=cd90, createdTime=Sun Apr 05 20:43:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19541, encodeId=89f1195413b, content=会死人的病, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xiaoai5777, createdTime=Sun Apr 05 19:55:00 CST 2015, time=2015-04-05, status=1, ipAttribution=)]
    2015-04-05 xiaoai5777

    会死人的病

    0

相关资讯

NEJM:血压治疗指标差异或不影响感染性休克死亡率

根据拯救败血症患者运动(SSC)指南推荐,在临床救治感染性休克患者的早期复苏阶段,治疗者应保证患者的平均动脉压至少达到65mmHg。但是,实际的情况是,我们并不清楚指南推荐的血压治疗指标与较高血压治疗指标在临床治疗效果上的差异。法国研究者Asfar教授就上述问题开展了研究,其研究成果发表于3月18日的NEJM杂志。研究者进行了一个多中心开放性试验,776名患者入组,均换感染性休克并接受了复苏治疗。

NEJM:程序化标准治疗感染性休克不降低死亡率

3月18日,NEJM发布了早期感染性休克程序化治疗研究(Trial of Protocol-Based Care for Early Septic Shock,ProCESS)结果。【原文下载】ProCESS研究的提出是基于10多年前一个感染性休克的单中心研究,该研究提出:相比常规治疗,6小时程序化EGDT(early goal-directed therapy )治疗可降低严重感染患者和脓毒性休

JAMA:重症感染及感染性休克死亡率下降

重症感染和感染性休克是重症监护病房(ICU)危重患者死亡的主要原因。 过去20年中,多个随机对照临床试验(RCT)试图找出新的治疗方法,以提高危重患者的生存率。目前对于降低重症感染和感染性休克患者死亡率诊疗方法的研究进展情况尚不得而知。【原文下载】3月18日,JAMA在线发表了一项来自澳大利亚及新西兰重症医学研究中心的长期趋势研究结果,显示在2000-2012年,澳大利亚和新西兰的重症感染以及有/

Medscape:血压治疗指标不一定适用于感染性休克

在医学院里学习了自动调节曲线确定血压(BP)和器官灌注的关系。血压是不固定的,其与阻力有关,而阻力与血管的直径有关。 在一定范围内的血压,器官灌注量是足够的。而该范围随器官和病人的因素而变化,例如年龄和合并症。当血管收缩使血压升高超过该范围,血流的阻力增加(由于直径的减小),器官灌注量无法保持。同样的,当血管舒张使血压下降超过该范围时,血流的驱动压力下降,器官的灌注量再次受损。 重症医学会的《

Medpage:新证据显示感染性休克指南需要修订

3月份,研究人员公布了他们期待已久的早期目标导向治疗的研究结果。一些急诊医师表示,新的研究结果清楚地表明,治疗感染性休克的指南应该修订了。 该试验的名称为早期感染性休克临床治疗(ProCESS)试验。该试验发现在常规治疗感染性休克的过程中植入中心静脉导管测量静脉血气和氧饱和度并没有带来什么好处。 研究数据表明中心静脉导管[CVC]使用与否并不影响临床结局。该试验的主要作者之一唐纳德博士表示

JAMA:感染性休克患者应用β阻滞剂可达目标心率且不增加不良结局

研究要点: 1.感染性休克与心功能不良反应有关,β阻滞剂可控制心率但可能导致心血管代偿失调。 2.Andrea Morelli等人研究了短效β阻滞剂艾司洛尔对高死亡风险的严重感染性休克患者心率的影响。 3.结果发现β阻滞剂治疗感染性休克患者可达到目标心率,且不会增加不良结局,结果发表于《美国医学会杂志》。 感染性休克与心功能不良反应有关。β阻滞剂治疗可控制心率,并可改善心血管表现,但β阻滞